Moderna oncology executive Michelle Brown on experimental melanoma vaccine
WPTF Morning News · WPTF FM 92.9 AM 680
February 6, 20269m 47s
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Moderna Vice President and oncology portfolio lead Michelle Brown explains the newly announced experimental melanoma vaccine developed with Merck, how it works alongside the immunotherapy Keytruda, what the latest data show about lowering the risk of cancer returning, and what this could mean for patients moving forward.